Explore the latest trends and actionable insights on the Microbiome-Targeting Therapeutics market to inform business strategy and pinpoint opportunities and risks

Middle East and Africa: Top Microbiome Patents Holders (2002 - 2022)

  • With 95 Microbiome related patents published between 2002 and 2022, 4D Pharma Plc holds the most number of Microbiome patents in the Middle East and Africa region, of which 61.1% was contributed by its subsidiary 4D Pharma Research Ltd.

  • The second largest number of Microbiome related patents were published by BioGaia AB with 18 patents. The third largest number of Microbiome related patents were published by Nestle SA with 15 patents. The fourth largest number of Microbiome related patents were published by Snipr Technologies Limited with 15 patents. The fifth largest number of Microbiome related patents were published by Rebiotix Inc with 13 patents.

  • The top five patent holders, i.e., 4D Pharma Plc, BioGaia AB, Nestle SA, Snipr Technologies Limited, and Rebiotix Inc, together held 156 Microbiome patents during the period.

Middle East and Africa: Top Microbiome Patents Holders (2002 - 2022)

Note: The number of patents includes patents published by the holding company and its subsidiaries (data till October 2022)
Published: November 2022
Source: GlobalData

Explore the latest trends and actionable insights on the Microbiome-Targeting Therapeutics market to inform business strategy and pinpoint opportunities and risks Explore the latest trends and actionable insights on the Microbiome-Targeting Therapeutics market to inform business strategy and pinpoint opportunities and risks Visit Report Store
Still looking?

Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward